Business
Medical Marijuana, Inc. Opens New Production & Warehousing Facility to Expedite International Expansion Efforts
Medical Marijuana, Inc. Opens New Production & Warehousing Facility to Expedite International Expansion Efforts.
About this update from Medical Marijuana, Inc.
[{"type":"text","content":"\nThe Company has expanded into a new, larger production and warehouse facility to meet the increasing retail and consumer demand for the Company’s cannabidiol (CBD) hemp oil productsThe facility is cGMP compliant and registered with the State of UtahMedical Marijuana, Inc. aims to increase production and warehousing capabilities SAN DIEGO, July 23, 2019 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today the expansion of its operations with a new production and warehouse facility.\n The facility, covering 16,000 square feet, is cGMP compliant and is registered with the State of Utah. The facility has been designed to help the Company increase warehousing, fulfillment and production activities related to the Company’s CBD hemp oil products. “As the Company has seen a significant rise in sales and overall revenue this year, we believe that this new facility will help us strengthen our customer base and meet the needs of today’s burgeoning cannabis market,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “Our team is working diligently to create processes that will guarantee that this facility will create more transparent and valuable relationships with retailers and consumers around the world.” Medical Marijuana, Inc. recently announced that the Company is in the process of expanding its operations in the U.S. and Latin American to reach new markets in Europe and Asia and this facility will support the increased domestic and international production needs. “Medical Marijuana, Inc. is the first company in the U.S. to create a CBD product pipeline and we intend to continue to pioneer the industry as we open this facility. This new facility will enable us to continue improvement of our operation, and reduce materially our cost of goods expense as we continue to grow revenue and expand opportunities for the company,” said Medical Marijuana, Inc. COO Blake Schroeder. “This showcases our commitment to remaining an industry leader and continuing to provide our customers, retailers and shareholders with the assurance and value of quality products and op...